Project factsheets

Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

ALL # A B C D E F G H I K L M N O P Q R S T U V W Z

Clear all filters

Displaying 15 projects and 0 programmes

AUTOPIX

Imaging for patient benefit in arthritis

CLAIMS

Clinical impact through AI-assisted MS care

Ongoing IHI Autoimmune diseases Big data and knowledge management Artificial intelligence

INTERCEPT

Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing interception of full-blown disease development

Ongoing IHI Autoimmune diseases Tools for predicting/monitoring efficacy Conducting clinical trials

3TR

Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions

Ongoing IMI2 Respiratory diseases Autoimmune diseases Tools for predicting/monitoring efficacy Biobanks Disease taxonomy

BIOMAP

Biomarkers in atopic dermatitis and psoriasis

Ongoing IMI2 Autoimmune diseases Skin diseases Biobanks Disease taxonomy

H2O

H2O Health outcomes observatory

Ongoing IMI2 Diabetes & metabolic disorders Autoimmune diseases Cancer Patient involvement in R&D Real-world data, evidence

HIPPOCRATES

Health initiatives in psoriasis and psoriatic arthritis consortium European states

Ongoing IMI2 Autoimmune diseases Skin diseases Biobanks Clinical networks Disease taxonomy Artificial intelligence

IDEA-FAST

Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases

Ongoing IMI2 Neurodegenerative diseases Autoimmune diseases Clinical trial design Digital health Real-world data, evidence

ImmUniverse

Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

Ongoing IMI2 Autoimmune diseases Skin diseases Tools for predicting/monitoring efficacy Disease taxonomy

imSAVAR

Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Ongoing IMI2 Autoimmune diseases Cancer 3Rs - animal use in research

NECESSITY

New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients

Ongoing IMI2 Autoimmune diseases Tools for predicting/monitoring efficacy Clinical trial design Disease taxonomy

RTCure

Rheuma Tolerance for Cure

Closed IMI2 Autoimmune diseases Biologicals Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety Disease taxonomy

BTCure

Be The Cure

Closed IMI1 Autoimmune diseases Tools for predicting/monitoring safety Disease taxonomy

PRECISESADS

Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases

Closed IMI1 Autoimmune diseases Diagnostics Conducting clinical trials

ULTRA-DD

Unrestricted leveraging of targets for research advancement and drug discovery

Closed IMI1 Autoimmune diseases Drug discovery